Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Innovita Biological Technology Co's Days Inventory or its related term are showing as below:
SHSE:688253'
s Days Inventory Range Over the Past 10 Years
Min: 84.91 Med: 177.88 Max: 216.67
Current: 216.13
During the past 8 years, Innovita Biological Technology Co's highest Days Inventory was 216.67. The lowest was 84.91. And the median was 177.88.
SHSE:688253's Days Inventory is ranked worse than 57.68% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs SHSE:688253: 216.13
Inventory Turnover measures how fast the company turns over its inventory within a year.
Innovita Biological Technology Co's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.50.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Innovita Biological Technology Co's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.47.
Innovita Biological Technology Co (SHSE:688253) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Innovita Biological Technology Co's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Innovita Biological Technology Co's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Innovita Biological Technology Co Days Inventory Related Terms
Innovita Biological Technology Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Innovita Biological Technology Co Days Inventory Chart
SHSE:688253 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Innovita Biological Technology Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Innovita Biological Technology Co Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Innovita Biological Technology Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Innovita Biological Technology Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Innovita Biological Technology Co (SHSE:688253) has a Days Inventory of 181.29 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Innovita Biological Technology Co and its competitors. This is near median its historical median of 177.88. Over the past decade, Innovita Biological Technology Co's Days Inventory has ranged from 84.91 to 216.67. According to the industry distribution chart, Innovita Biological Technology Co ranks #368 out of 638 companies in the Biotechnology industry, placing it in the top 57.7%.
Is Innovita Biological Technology Co's Days Inventory too high?
Innovita Biological Technology Co's current Days Inventory of 181.29 is near median its 10-year median of 177.88. Over the past 10 years, this metric has ranged from a low of 84.91 to a high of 216.67. The Biotechnology industry median Days Inventory is 183.20. Innovita Biological Technology Co's value of 181.29 is 1% below this industry median. Based on the distribution chart, Innovita Biological Technology Co ranks #368 out of 638 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Innovita Biological Technology Co has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Innovita Biological Technology Co's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Innovita Biological Technology Co ranks #368 out of 638 companies for Days Inventory. This places Innovita Biological Technology Co in the lower half of its industry. The industry median Days Inventory is 183.20. Innovita Biological Technology Co's value of 181.29 is 1% below this benchmark. Historically, Innovita Biological Technology Co's own Days Inventory has ranged from 84.91 to 216.67 over the past decade. While the company's 10-year median is 177.88 vs. the industry median of 183.20, Innovita Biological Technology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Innovita Biological Technology Co's current Days Inventory of 181.29 is 1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Innovita Biological Technology Co and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innovita Biological Technology Co's current Days Inventory is 181.29, which is near median its own 10-year median of 177.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovita Biological Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Innovita Biological Technology Co (SHSE:688253) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥20.50, compared to a current price of ¥50.01 — trading 144% above its estimated fair value. The current Days Inventory is 181.29, which is near median its 10-year median of 177.88 and 1% below the Biotechnology industry median of 183.20. Innovita Biological Technology Co's overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Innovita Biological Technology Co (SHSE:688253), the current Days Inventory is 181.29 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Innovita Biological Technology Co (SHSE:688253) Overvalued in 2026?
Based on GuruFocus' analysis, Innovita Biological Technology Co stock appears to be overvalued.
The current stock price of ¥50.01 is trading 144% above its estimated GF Value™ of ¥20.50.
GuruFocus considers Innovita Biological Technology Co to be Significantly Overvalued.
Key valuation signals for SHSE:688253:
Days Inventory: 181.29 (near median its 10-year median of 177.88)
GF Value™: ¥20.50 vs. price of ¥50.01 (144% above fair value)
Industry Position: 1% below the Biotechnology median (#368 of 638)
No single metric tells the full story. See the SHSE:688253 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Innovita Biological Technology Co Business Description
Innovita Biological Technology Co Ltd is a biotechnology company focusing on the research and development, production, and sales of POCT in vitro diagnostic products.
61GF Score
Get the complete analysis for SHSE:688253
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688253 has been successfully added to your 
